[EN] NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS<br/>[FR] NOUVEAUX DÉRIVÉS DE SPIROCYCLOHEXANE, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET LEURS UTILISATIONS COMME INHIBITEURS ANTI-APOPTOTIQUES
申请人:SERVIER LAB
公开号:WO2024008941A1
公开(公告)日:2024-01-11
Compounds of Formula (I): wherein R1, R2, R3, R4and are as defined in the description. Medicaments.
式 (I) 的化合物:其中 R1、R2、R3、R4 和如描述中所定义。药物。
Paden; Adkins, Journal of the American Chemical Society, 1936, vol. 58, p. 2493
作者:Paden、Adkins
DOI:——
日期:——
Kralt,T. et al., Recueil des Travaux Chimiques des Pays-Bas, 1961, vol. 80, p. 330 - 357
作者:Kralt,T. et al.
DOI:——
日期:——
BIR DOMAIN BINDING COMPOUNDS
申请人:Jarvis Scott
公开号:US20100292269A1
公开(公告)日:2010-11-18
The present invention is directed towards an isomer, an enantiomer, a diastereoisomer, or a tautomer of a pyrrolidine compound represented by Formula I:
in which the substituents R
1
, R
1a
, R
2
, R
2a
, R
3
, A and Q are defined herein; or a prodrug, or a salt thereof, and which bind to IAP BIR domains. In particular, the compounds are useful in treating proliferative disorders such as cancer
Templated assembly of medium cyclic ethers via exo-trig nucleophilic cyclization of cyclopropenes
作者:Bassam K. Alnasleh、Marina Rubina、Michael Rubin
DOI:10.1039/c6cc02178f
日期:——
A novel method for the assembly of medium heterocycles via an intramolecular nucleophilic addition to cyclopropenes generated in situ from the corresponding bromocyclopropanes is described. The exo-trig nucleophilic cyclizations were...